Hotline: +86-18022463983    020-85206863

Global Fast Protein-free Blocking Buffer Market Research Report 2026

Published Date: 2026-01-22   |   Pages: 137   |   Tables: 131   |  Medical Devices & Consumables

The global Fast Protein-free Blocking Buffer market was valued at US$ 489 million in 2025 and is anticipated to reach US$ 708 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Fast Protein-free Blocking Buffer competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Protein-free Rapid Blocking Solution is a ready-to-use, efficient and rapid blocking solution for western blot experiments. The blocking time is only 10 minutes, and the effect is better than traditional blocking solutions such as skim milk powder, BSA, casein, etc., simplifying the western blot protocol. Blocking with Rapid Blocking Solution can prevent non-specific binding during antibody detection, but allow specific detection. Compared with traditional blocking solutions, there is a higher signal, lower background value, and higher signal-to-noise ratio.
The North American market for Fast Protein-free Blocking Buffer is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Fast Protein-free Blocking Buffer is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Fast Protein-free Blocking Buffer include Meilunbio, Solarbio, Changzhou Boyi Biotechnology Co., Ltd., Shanghai Yamay Biomedical Technology Co., Ltd., Boster Biologica, Beijing Kang Runcheng Industry Biotechnology Co., Ltd., Life-ilab, Hubei Pumei Biotechnology Co., Ltd., Beijing Botes Biotechnology Co., Ltd., Biosharp, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Fast Protein-free Blocking Buffer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Fast Protein-free Blocking Buffer. The Fast Protein-free Blocking Buffer market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Fast Protein-free Blocking Buffer market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Fast Protein-free Blocking Buffer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Meilunbio
Solarbio
Changzhou Boyi Biotechnology Co., Ltd.
Shanghai Yamay Biomedical Technology Co., Ltd.
Boster Biologica
Beijing Kang Runcheng Industry Biotechnology Co., Ltd.
Life-ilab
Hubei Pumei Biotechnology Co., Ltd.
Beijing Botes Biotechnology Co., Ltd.
Biosharp
Thermo Fisher Scientific
Applygen
Yoche Biotechnology
Servicebio
Ecotopbio
LI-COR Biotech
Geno Technology Inc.
Visual Protein
Azure Biosystems Inc.
Segment by Type
500ML
1000ML
by Application
University
Laboratory
Hospital
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Fast Protein-free Blocking Buffer manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Fast Protein-free Blocking Buffer sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Fast Protein-free Blocking Buffer Market Overview
1.1 Product Definition
1.2 Fast Protein-free Blocking Buffer by Type
1.2.1 Global Fast Protein-free Blocking Buffer Market Value by Type: 2025 vs 2032
1.2.2 500ML
1.2.3 1000ML
1.3 Fast Protein-free Blocking Buffer by Application
1.3.1 Global Fast Protein-free Blocking Buffer Market Value by Application: 2025 vs 2032
1.3.2 University
1.3.3 Laboratory
1.3.4 Hospital
1.3.5 Others
1.4 Global Fast Protein-free Blocking Buffer Market Size Estimates and Forecasts
1.4.1 Global Fast Protein-free Blocking Buffer Revenue 2021–2032
1.4.2 Global Fast Protein-free Blocking Buffer Sales 2021–2032
1.4.3 Global Fast Protein-free Blocking Buffer Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Fast Protein-free Blocking Buffer Market Competition by Manufacturers
2.1 Global Fast Protein-free Blocking Buffer Sales Market Share by Manufacturers (2021–2026)
2.2 Global Fast Protein-free Blocking Buffer Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Fast Protein-free Blocking Buffer Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Fast Protein-free Blocking Buffer, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Fast Protein-free Blocking Buffer, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Fast Protein-free Blocking Buffer, Product Types and Applications
2.7 Global Key Manufacturers of Fast Protein-free Blocking Buffer, Date of Entry into the Industry
2.8 Global Fast Protein-free Blocking Buffer Market Competitive Situation and Trends
2.8.1 Global Fast Protein-free Blocking Buffer Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Fast Protein-free Blocking Buffer Players Market Share by Revenue
2.8.3 Global Fast Protein-free Blocking Buffer Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fast Protein-free Blocking Buffer Market Scenario by Region
3.1 Global Fast Protein-free Blocking Buffer Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Fast Protein-free Blocking Buffer Sales by Region: 2021–2032
3.2.1 Global Fast Protein-free Blocking Buffer Sales by Region: 2021–2026
3.2.2 Global Fast Protein-free Blocking Buffer Sales by Region: 2027–2032
3.3 Global Fast Protein-free Blocking Buffer Revenue by Region: 2021–2032
3.3.1 Global Fast Protein-free Blocking Buffer Revenue by Region: 2021–2026
3.3.2 Global Fast Protein-free Blocking Buffer Revenue by Region: 2027–2032
3.4 North America Fast Protein-free Blocking Buffer Market Facts & Figures by Country
3.4.1 North America Fast Protein-free Blocking Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Fast Protein-free Blocking Buffer Sales by Country (2021–2032)
3.4.3 North America Fast Protein-free Blocking Buffer Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fast Protein-free Blocking Buffer Market Facts & Figures by Country
3.5.1 Europe Fast Protein-free Blocking Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Fast Protein-free Blocking Buffer Sales by Country (2021–2032)
3.5.3 Europe Fast Protein-free Blocking Buffer Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fast Protein-free Blocking Buffer Market Facts & Figures by Region
3.6.1 Asia Pacific Fast Protein-free Blocking Buffer Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Fast Protein-free Blocking Buffer Sales by Region (2021–2032)
3.6.3 Asia Pacific Fast Protein-free Blocking Buffer Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fast Protein-free Blocking Buffer Market Facts & Figures by Country
3.7.1 Latin America Fast Protein-free Blocking Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Fast Protein-free Blocking Buffer Sales by Country (2021–2032)
3.7.3 Latin America Fast Protein-free Blocking Buffer Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fast Protein-free Blocking Buffer Market Facts & Figures by Country
3.8.1 Middle East and Africa Fast Protein-free Blocking Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Fast Protein-free Blocking Buffer Sales by Country (2021–2032)
3.8.3 Middle East and Africa Fast Protein-free Blocking Buffer Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fast Protein-free Blocking Buffer Sales by Type (2021–2032)
4.1.1 Global Fast Protein-free Blocking Buffer Sales by Type (2021–2026)
4.1.2 Global Fast Protein-free Blocking Buffer Sales by Type (2027–2032)
4.1.3 Global Fast Protein-free Blocking Buffer Sales Market Share by Type (2021–2032)
4.2 Global Fast Protein-free Blocking Buffer Revenue by Type (2021–2032)
4.2.1 Global Fast Protein-free Blocking Buffer Revenue by Type (2021–2026)
4.2.2 Global Fast Protein-free Blocking Buffer Revenue by Type (2027–2032)
4.2.3 Global Fast Protein-free Blocking Buffer Revenue Market Share by Type (2021–2032)
4.3 Global Fast Protein-free Blocking Buffer Price by Type (2021–2032)
5 Segment by Application
5.1 Global Fast Protein-free Blocking Buffer Sales by Application (2021–2032)
5.1.1 Global Fast Protein-free Blocking Buffer Sales by Application (2021–2026)
5.1.2 Global Fast Protein-free Blocking Buffer Sales by Application (2027–2032)
5.1.3 Global Fast Protein-free Blocking Buffer Sales Market Share by Application (2021–2032)
5.2 Global Fast Protein-free Blocking Buffer Revenue by Application (2021–2032)
5.2.1 Global Fast Protein-free Blocking Buffer Revenue by Application (2021–2026)
5.2.2 Global Fast Protein-free Blocking Buffer Revenue by Application (2027–2032)
5.2.3 Global Fast Protein-free Blocking Buffer Revenue Market Share by Application (2021–2032)
5.3 Global Fast Protein-free Blocking Buffer Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Meilunbio
6.1.1 Meilunbio Company Information
6.1.2 Meilunbio Description and Business Overview
6.1.3 Meilunbio Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Meilunbio Fast Protein-free Blocking Buffer Product Portfolio
6.1.5 Meilunbio Recent Developments/Updates
6.2 Solarbio
6.2.1 Solarbio Company Information
6.2.2 Solarbio Description and Business Overview
6.2.3 Solarbio Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Solarbio Fast Protein-free Blocking Buffer Product Portfolio
6.2.5 Solarbio Recent Developments/Updates
6.3 Changzhou Boyi Biotechnology Co., Ltd.
6.3.1 Changzhou Boyi Biotechnology Co., Ltd. Company Information
6.3.2 Changzhou Boyi Biotechnology Co., Ltd. Description and Business Overview
6.3.3 Changzhou Boyi Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Changzhou Boyi Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product Portfolio
6.3.5 Changzhou Boyi Biotechnology Co., Ltd. Recent Developments/Updates
6.4 Shanghai Yamay Biomedical Technology Co., Ltd.
6.4.1 Shanghai Yamay Biomedical Technology Co., Ltd. Company Information
6.4.2 Shanghai Yamay Biomedical Technology Co., Ltd. Description and Business Overview
6.4.3 Shanghai Yamay Biomedical Technology Co., Ltd. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shanghai Yamay Biomedical Technology Co., Ltd. Fast Protein-free Blocking Buffer Product Portfolio
6.4.5 Shanghai Yamay Biomedical Technology Co., Ltd. Recent Developments/Updates
6.5 Boster Biologica
6.5.1 Boster Biologica Company Information
6.5.2 Boster Biologica Description and Business Overview
6.5.3 Boster Biologica Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Boster Biologica Fast Protein-free Blocking Buffer Product Portfolio
6.5.5 Boster Biologica Recent Developments/Updates
6.6 Beijing Kang Runcheng Industry Biotechnology Co., Ltd.
6.6.1 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Company Information
6.6.2 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product Portfolio
6.6.5 Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Recent Developments/Updates
6.7 Life-ilab
6.7.1 Life-ilab Company Information
6.7.2 Life-ilab Description and Business Overview
6.7.3 Life-ilab Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Life-ilab Fast Protein-free Blocking Buffer Product Portfolio
6.7.5 Life-ilab Recent Developments/Updates
6.8 Hubei Pumei Biotechnology Co., Ltd.
6.8.1 Hubei Pumei Biotechnology Co., Ltd. Company Information
6.8.2 Hubei Pumei Biotechnology Co., Ltd. Description and Business Overview
6.8.3 Hubei Pumei Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hubei Pumei Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product Portfolio
6.8.5 Hubei Pumei Biotechnology Co., Ltd. Recent Developments/Updates
6.9 Beijing Botes Biotechnology Co., Ltd.
6.9.1 Beijing Botes Biotechnology Co., Ltd. Company Information
6.9.2 Beijing Botes Biotechnology Co., Ltd. Description and Business Overview
6.9.3 Beijing Botes Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing Botes Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product Portfolio
6.9.5 Beijing Botes Biotechnology Co., Ltd. Recent Developments/Updates
6.10 Biosharp
6.10.1 Biosharp Company Information
6.10.2 Biosharp Description and Business Overview
6.10.3 Biosharp Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biosharp Fast Protein-free Blocking Buffer Product Portfolio
6.10.5 Biosharp Recent Developments/Updates
6.11 Thermo Fisher Scientific
6.11.1 Thermo Fisher Scientific Company Information
6.11.2 Thermo Fisher Scientific Description and Business Overview
6.11.3 Thermo Fisher Scientific Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Thermo Fisher Scientific Fast Protein-free Blocking Buffer Product Portfolio
6.11.5 Thermo Fisher Scientific Recent Developments/Updates
6.12 Applygen
6.12.1 Applygen Company Information
6.12.2 Applygen Description and Business Overview
6.12.3 Applygen Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Applygen Fast Protein-free Blocking Buffer Product Portfolio
6.12.5 Applygen Recent Developments/Updates
6.13 Yoche Biotechnology
6.13.1 Yoche Biotechnology Company Information
6.13.2 Yoche Biotechnology Description and Business Overview
6.13.3 Yoche Biotechnology Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yoche Biotechnology Fast Protein-free Blocking Buffer Product Portfolio
6.13.5 Yoche Biotechnology Recent Developments/Updates
6.14 Servicebio
6.14.1 Servicebio Company Information
6.14.2 Servicebio Description and Business Overview
6.14.3 Servicebio Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Servicebio Fast Protein-free Blocking Buffer Product Portfolio
6.14.5 Servicebio Recent Developments/Updates
6.15 Ecotopbio
6.15.1 Ecotopbio Company Information
6.15.2 Ecotopbio Description and Business Overview
6.15.3 Ecotopbio Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Ecotopbio Fast Protein-free Blocking Buffer Product Portfolio
6.15.5 Ecotopbio Recent Developments/Updates
6.16 LI-COR Biotech
6.16.1 LI-COR Biotech Company Information
6.16.2 LI-COR Biotech Description and Business Overview
6.16.3 LI-COR Biotech Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 LI-COR Biotech Fast Protein-free Blocking Buffer Product Portfolio
6.16.5 LI-COR Biotech Recent Developments/Updates
6.17 Geno Technology Inc.
6.17.1 Geno Technology Inc. Company Information
6.17.2 Geno Technology Inc. Description and Business Overview
6.17.3 Geno Technology Inc. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Geno Technology Inc. Fast Protein-free Blocking Buffer Product Portfolio
6.17.5 Geno Technology Inc. Recent Developments/Updates
6.18 Visual Protein
6.18.1 Visual Protein Company Information
6.18.2 Visual Protein Description and Business Overview
6.18.3 Visual Protein Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Visual Protein Fast Protein-free Blocking Buffer Product Portfolio
6.18.5 Visual Protein Recent Developments/Updates
6.19 Azure Biosystems Inc.
6.19.1 Azure Biosystems Inc. Company Information
6.19.2 Azure Biosystems Inc. Description and Business Overview
6.19.3 Azure Biosystems Inc. Fast Protein-free Blocking Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Azure Biosystems Inc. Fast Protein-free Blocking Buffer Product Portfolio
6.19.5 Azure Biosystems Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fast Protein-free Blocking Buffer Industry Chain Analysis
7.2 Fast Protein-free Blocking Buffer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fast Protein-free Blocking Buffer Production Mode & Process Analysis
7.4 Fast Protein-free Blocking Buffer Sales and Marketing
7.4.1 Fast Protein-free Blocking Buffer Sales Channels
7.4.2 Fast Protein-free Blocking Buffer Distributors
7.5 Fast Protein-free Blocking Buffer Customer Analysis
8 Fast Protein-free Blocking Buffer Market Dynamics
8.1 Fast Protein-free Blocking Buffer Industry Trends
8.2 Fast Protein-free Blocking Buffer Market Drivers
8.3 Fast Protein-free Blocking Buffer Market Challenges
8.4 Fast Protein-free Blocking Buffer Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Fast Protein-free Blocking Buffer Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Fast Protein-free Blocking Buffer Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Fast Protein-free Blocking Buffer Market Competitive Situation by Manufacturers in 2025
Table 4. Global Fast Protein-free Blocking Buffer Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Fast Protein-free Blocking Buffer Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Fast Protein-free Blocking Buffer Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Fast Protein-free Blocking Buffer Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Fast Protein-free Blocking Buffer Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Fast Protein-free Blocking Buffer, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Fast Protein-free Blocking Buffer, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Fast Protein-free Blocking Buffer, Product Types and Applications
Table 12. Global Key Manufacturers of Fast Protein-free Blocking Buffer, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fast Protein-free Blocking Buffer Companies by Tier (Tier 1, Tier 2, Tier 3), based on Fast Protein-free Blocking Buffer Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fast Protein-free Blocking Buffer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Fast Protein-free Blocking Buffer Sales by Region (K Units), 2021–2026
Table 18. Global Fast Protein-free Blocking Buffer Sales Market Share by Region (2021–2026)
Table 19. Global Fast Protein-free Blocking Buffer Sales by Region (K Units), 2027–2032
Table 20. Global Fast Protein-free Blocking Buffer Sales Market Share by Region (2027–2032)
Table 21. Global Fast Protein-free Blocking Buffer Revenue by Region (US$ Million), 2021–2026
Table 22. Global Fast Protein-free Blocking Buffer Revenue Market Share by Region (2021–2026)
Table 23. Global Fast Protein-free Blocking Buffer Revenue by Region (US$ Million), 2027–2032
Table 24. Global Fast Protein-free Blocking Buffer Revenue Market Share by Region (2027–2032)
Table 25. North America Fast Protein-free Blocking Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Fast Protein-free Blocking Buffer Sales by Country (K Units), 2021–2026
Table 27. North America Fast Protein-free Blocking Buffer Sales by Country (K Units), 2027–2032
Table 28. North America Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2021–2026
Table 29. North America Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Fast Protein-free Blocking Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Fast Protein-free Blocking Buffer Sales by Country (K Units), 2021–2026
Table 32. Europe Fast Protein-free Blocking Buffer Sales by Country (K Units), 2027–2032
Table 33. Europe Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Fast Protein-free Blocking Buffer Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Fast Protein-free Blocking Buffer Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Fast Protein-free Blocking Buffer Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Fast Protein-free Blocking Buffer Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Fast Protein-free Blocking Buffer Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Fast Protein-free Blocking Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Fast Protein-free Blocking Buffer Sales by Country (K Units), 2021–2026
Table 42. Latin America Fast Protein-free Blocking Buffer Sales by Country (K Units), 2027–2032
Table 43. Latin America Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Fast Protein-free Blocking Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Fast Protein-free Blocking Buffer Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Fast Protein-free Blocking Buffer Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Fast Protein-free Blocking Buffer Revenue by Country (US$ Million), 2027–2032
Table 50. Global Fast Protein-free Blocking Buffer Sales (K Units) by Type (2021–2026)
Table 51. Global Fast Protein-free Blocking Buffer Sales (K Units) by Type (2027–2032)
Table 52. Global Fast Protein-free Blocking Buffer Sales Market Share by Type (2021–2026)
Table 53. Global Fast Protein-free Blocking Buffer Sales Market Share by Type (2027–2032)
Table 54. Global Fast Protein-free Blocking Buffer Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Fast Protein-free Blocking Buffer Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Fast Protein-free Blocking Buffer Revenue Market Share by Type (2021–2026)
Table 57. Global Fast Protein-free Blocking Buffer Revenue Market Share by Type (2027–2032)
Table 58. Global Fast Protein-free Blocking Buffer Price (US$/Unit) by Type (2021–2026)
Table 59. Global Fast Protein-free Blocking Buffer Price (US$/Unit) by Type (2027–2032)
Table 60. Global Fast Protein-free Blocking Buffer Sales (K Units) by Application (2021–2026)
Table 61. Global Fast Protein-free Blocking Buffer Sales (K Units) by Application (2027–2032)
Table 62. Global Fast Protein-free Blocking Buffer Sales Market Share by Application (2021–2026)
Table 63. Global Fast Protein-free Blocking Buffer Sales Market Share by Application (2027–2032)
Table 64. Global Fast Protein-free Blocking Buffer Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Fast Protein-free Blocking Buffer Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Fast Protein-free Blocking Buffer Revenue Market Share by Application (2021–2026)
Table 67. Global Fast Protein-free Blocking Buffer Revenue Market Share by Application (2027–2032)
Table 68. Global Fast Protein-free Blocking Buffer Price (US$/Unit) by Application (2021–2026)
Table 69. Global Fast Protein-free Blocking Buffer Price (US$/Unit) by Application (2027–2032)
Table 70. Meilunbio Company Information
Table 71. Meilunbio Description and Business Overview
Table 72. Meilunbio Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Meilunbio Fast Protein-free Blocking Buffer Product
Table 74. Meilunbio Recent Developments/Updates
Table 75. Solarbio Company Information
Table 76. Solarbio Description and Business Overview
Table 77. Solarbio Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Solarbio Fast Protein-free Blocking Buffer Product
Table 79. Solarbio Recent Developments/Updates
Table 80. Changzhou Boyi Biotechnology Co., Ltd. Company Information
Table 81. Changzhou Boyi Biotechnology Co., Ltd. Description and Business Overview
Table 82. Changzhou Boyi Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Changzhou Boyi Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product
Table 84. Changzhou Boyi Biotechnology Co., Ltd. Recent Developments/Updates
Table 85. Shanghai Yamay Biomedical Technology Co., Ltd. Company Information
Table 86. Shanghai Yamay Biomedical Technology Co., Ltd. Description and Business Overview
Table 87. Shanghai Yamay Biomedical Technology Co., Ltd. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Shanghai Yamay Biomedical Technology Co., Ltd. Fast Protein-free Blocking Buffer Product
Table 89. Shanghai Yamay Biomedical Technology Co., Ltd. Recent Developments/Updates
Table 90. Boster Biologica Company Information
Table 91. Boster Biologica Description and Business Overview
Table 92. Boster Biologica Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Boster Biologica Fast Protein-free Blocking Buffer Product
Table 94. Boster Biologica Recent Developments/Updates
Table 95. Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Company Information
Table 96. Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Description and Business Overview
Table 97. Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product
Table 99. Beijing Kang Runcheng Industry Biotechnology Co., Ltd. Recent Developments/Updates
Table 100. Life-ilab Company Information
Table 101. Life-ilab Description and Business Overview
Table 102. Life-ilab Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Life-ilab Fast Protein-free Blocking Buffer Product
Table 104. Life-ilab Recent Developments/Updates
Table 105. Hubei Pumei Biotechnology Co., Ltd. Company Information
Table 106. Hubei Pumei Biotechnology Co., Ltd. Description and Business Overview
Table 107. Hubei Pumei Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Hubei Pumei Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product
Table 109. Hubei Pumei Biotechnology Co., Ltd. Recent Developments/Updates
Table 110. Beijing Botes Biotechnology Co., Ltd. Company Information
Table 111. Beijing Botes Biotechnology Co., Ltd. Description and Business Overview
Table 112. Beijing Botes Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Beijing Botes Biotechnology Co., Ltd. Fast Protein-free Blocking Buffer Product
Table 114. Beijing Botes Biotechnology Co., Ltd. Recent Developments/Updates
Table 115. Biosharp Company Information
Table 116. Biosharp Description and Business Overview
Table 117. Biosharp Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Biosharp Fast Protein-free Blocking Buffer Product
Table 119. Biosharp Recent Developments/Updates
Table 120. Thermo Fisher Scientific Company Information
Table 121. Thermo Fisher Scientific Description and Business Overview
Table 122. Thermo Fisher Scientific Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Thermo Fisher Scientific Fast Protein-free Blocking Buffer Product
Table 124. Thermo Fisher Scientific Recent Developments/Updates
Table 125. Applygen Company Information
Table 126. Applygen Description and Business Overview
Table 127. Applygen Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Applygen Fast Protein-free Blocking Buffer Product
Table 129. Applygen Recent Developments/Updates
Table 130. Yoche Biotechnology Company Information
Table 131. Yoche Biotechnology Description and Business Overview
Table 132. Yoche Biotechnology Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Yoche Biotechnology Fast Protein-free Blocking Buffer Product
Table 134. Yoche Biotechnology Recent Developments/Updates
Table 135. Servicebio Company Information
Table 136. Servicebio Description and Business Overview
Table 137. Servicebio Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Servicebio Fast Protein-free Blocking Buffer Product
Table 139. Servicebio Recent Developments/Updates
Table 140. Ecotopbio Company Information
Table 141. Ecotopbio Description and Business Overview
Table 142. Ecotopbio Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Ecotopbio Fast Protein-free Blocking Buffer Product
Table 144. Ecotopbio Recent Developments/Updates
Table 145. LI-COR Biotech Company Information
Table 146. LI-COR Biotech Description and Business Overview
Table 147. LI-COR Biotech Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. LI-COR Biotech Fast Protein-free Blocking Buffer Product
Table 149. LI-COR Biotech Recent Developments/Updates
Table 150. Geno Technology Inc. Company Information
Table 151. Geno Technology Inc. Description and Business Overview
Table 152. Geno Technology Inc. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Geno Technology Inc. Fast Protein-free Blocking Buffer Product
Table 154. Geno Technology Inc. Recent Developments/Updates
Table 155. Visual Protein Company Information
Table 156. Visual Protein Description and Business Overview
Table 157. Visual Protein Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Visual Protein Fast Protein-free Blocking Buffer Product
Table 159. Visual Protein Recent Developments/Updates
Table 160. Azure Biosystems Inc. Company Information
Table 161. Azure Biosystems Inc. Description and Business Overview
Table 162. Azure Biosystems Inc. Fast Protein-free Blocking Buffer Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Azure Biosystems Inc. Fast Protein-free Blocking Buffer Product
Table 164. Azure Biosystems Inc. Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Fast Protein-free Blocking Buffer Distributors List
Table 168. Fast Protein-free Blocking Buffer Customers List
Table 169. Fast Protein-free Blocking Buffer Market Trends
Table 170. Fast Protein-free Blocking Buffer Market Drivers
Table 171. Fast Protein-free Blocking Buffer Market Challenges
Table 172. Fast Protein-free Blocking Buffer Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report


List of Figures
Figure 1. Product Picture of Fast Protein-free Blocking Buffer
Figure 2. Global Fast Protein-free Blocking Buffer Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Fast Protein-free Blocking Buffer Market Share by Type: 2025 & 2032
Figure 4. 500ML Product Picture
Figure 5. 1000ML Product Picture
Figure 6. Global Fast Protein-free Blocking Buffer Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Fast Protein-free Blocking Buffer Market Share by Application: 2025 & 2032
Figure 8. University
Figure 9. Laboratory
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Fast Protein-free Blocking Buffer Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Fast Protein-free Blocking Buffer Market Size (US$ Million), 2021–2032
Figure 14. Global Fast Protein-free Blocking Buffer Sales (K Units), 2021–2032
Figure 15. Global Fast Protein-free Blocking Buffer Average Price (US$/Unit), 2021–2032
Figure 16. Fast Protein-free Blocking Buffer Report Years Considered
Figure 17. Fast Protein-free Blocking Buffer Sales Share by Manufacturers in 2025
Figure 18. Global Fast Protein-free Blocking Buffer Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Fast Protein-free Blocking Buffer Players: Market Share by Revenue in Fast Protein-free Blocking Buffer in 2025
Figure 20. Fast Protein-free Blocking Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Fast Protein-free Blocking Buffer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Fast Protein-free Blocking Buffer Sales Market Share by Country (2021–2032)
Figure 23. North America Fast Protein-free Blocking Buffer Revenue Market Share by Country (2021–2032)
Figure 24. United States Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Fast Protein-free Blocking Buffer Sales Market Share by Country (2021–2032)
Figure 27. Europe Fast Protein-free Blocking Buffer Revenue Market Share by Country (2021–2032)
Figure 28. Germany Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Fast Protein-free Blocking Buffer Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Fast Protein-free Blocking Buffer Revenue Market Share by Region (2021–2032)
Figure 35. China Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Fast Protein-free Blocking Buffer Sales Market Share by Country (2021–2032)
Figure 43. Latin America Fast Protein-free Blocking Buffer Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Fast Protein-free Blocking Buffer Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Fast Protein-free Blocking Buffer Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Fast Protein-free Blocking Buffer Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Fast Protein-free Blocking Buffer by Type (2021–2032)
Figure 54. Global Revenue Market Share of Fast Protein-free Blocking Buffer by Type (2021–2032)
Figure 55. Global Fast Protein-free Blocking Buffer Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Fast Protein-free Blocking Buffer by Application (2021–2032)
Figure 57. Global Revenue Market Share of Fast Protein-free Blocking Buffer by Application (2021–2032)
Figure 58. Global Fast Protein-free Blocking Buffer Price (US$/Unit) by Application (2021–2032)
Figure 59. Fast Protein-free Blocking Buffer Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Our Clients